ImmunXperts
Identity
- Enterprise number
- 0552.755.587
- VAT number
- BE 0552.755.587
- Peppol ID
- 0208:0552755587
- Legal form
- Public limited company
- Status
- Active, normal situation
- Founded
- 16-05-2014
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- 5 June at 14:00deed of 20-05-2014 (in French)
- Peppol
- Reachable via PeppolFollow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- ImmunXperts in French
- Abbreviation
- IMXP in French
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 16-04-2020 (in French)
- Registered office in the articlesThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- Walloon Regiondeed of 16-04-2020 (in French)
Activities
NACEBEL 2025VAT activities
72101
Research and development on biotechnology main activity
Social security (RSZ) activities
72101
Research and development on biotechnology main activity
Joint committees annual accounts 2024
JC 207
White-collar workers in the chemical industry
Codes under NACEBEL 2008
VAT activities
72110
Scientific research and development main activity
Social security (RSZ) activities
72110
Scientific research and development main activity
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “Le développement et la fourniture de services d'analyse ou de prédiction d'effets secondaires des produits pharmaceutiques…”deed of 16-04-2020 (in French)
5 activities
- Le développement et la fourniture de services d'analyse ou de prédiction d'effets secondaires des produits pharmaceutiques, telle comme la biothérapie et les vaccins, particulièrement l'analyse de l'immunogénicité et des allergies.
- Le développement, la création, la validation et la commercialisation des tests biologiques en assays, servant à la recherche ainsi que le développement des produits pharmaceutiques, notamment la biothérapie et les vaccins, ainsi que l'évaluation des risques liés à de tels produits pharmaceutiques.
- L'offre de service de consultance et des conseils consultatifs au sujet du développement, de l'analyse et/ou l'optimalisation des produits pharmaceutiques, en ce compris mais pas limité à la biothérapie et aux vaccins, ainsi que l'évaluation des risques liés auxdits produits pharmaceutiques.
- La collection, l'analyse ainsi que le traitement à des fins de recherches scientifiques d'échantillons et de matériaux biologiques.
- La recherche et le développement des produits pharmaceutiques, ainsi que tout autre service ou produit lié au développement de produits pharmaceutiques.
Registered office and establishments
1 establishment| Establishment | Start date | Unit number |
|---|---|---|
| Rue Clément Ader 10 registered office 6041 Charleroi | ||
| IMXP Rue Clément Ader 16, 6041 Charleroi | 16-05-2014 | 2.231.201.819 |
Buildings and parcels at the addresses
- Ground area
- 3,131 m²
- Buildings
- 1,056 m²
- Volume, LiDAR
- 15,201 m³
- Tallest building
- 17.3 m
Buildings to scale, each on its own parcel
Parcels
| Parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 52028B0295/00B002 · establishment | 3,131 m² | 1 · 1,056 m² | 17.2 m · 5 |
Documents and sources
10 annual accounts at the NBBEntry in the KBO registerCoordinated articles of associationPeppol Directory
The latest accounts and deeds
Annual accounts at the NBB
- Annual accounts 2024filed on 08-07-2025
- Annual accounts 2023filed on 28-06-2024
- Annual accounts 2022filed on 16-08-2023
- Annual accounts 2021filed on 22-06-2022
Deeds in the Belgian Official Gazette
- Resignations & appointmentsdeed of 08-01-2026
- Registered officedeed of 02-02-2024
- Resignations & appointmentsdeed of 04-05-2023
- Resignations & appointmentsdeed of 14-02-2023